Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 19Neoplasms 18Cancer Pain 6Breast Neoplasms 5Breakthrough Pain 5Prostatic Neoplasms 4Lung Neoplasms 4Colonic Neoplasms 4Agnosia 4Rectal Neoplasms 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Chronic Pain 3Uterine Cervical Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Burns 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1

Interventions

Metformin 2Leuprolide 2Collagenases 2Clomiphene 2Streptozocin 1Spironolactone 1Propofol 1Prednisone 1Midazolam 1Mercaptopurine 1Melphalan 1Infliximab 1Fentanyl 1Cyclophosphamide 1Carmustine 1Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rare Diseases × Fentanyl × Clear all
NCT00004424 2015-03-25

Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy

FDA Office of Orphan Products Development

Phase NA Completed
120 enrolled

Respiration Disorders, Rare Diseases, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡